Search

everythinglearnresearchcommunity

for

Search:↓

Certain inhibitors can potentially treat prostate cancer and other hormone-dependent conditions by controlling sex hormone levels in cells.

Spironolactone, a heart and liver drug, has new uses including cancer treatment, viral infection prevention, and skin condition improvement.

Dermal papilla microtissues could be useful for initial hair growth drug testing.

Hair follicles affect how well small molecules can pass through the skin, and this varies depending on the molecule's features.

The document concludes that finasteride can reduce nandrolone detection in doping tests, suggesting frequent testing and setting metabolite level thresholds for detection.

Hair loss can cause emotional and social issues, and various treatments, including medication, surgery, and psychological support, are needed.

The document concludes that Catalyst software is effective for drug design, identifying potent compounds for various medical conditions.

Understanding how EDC genes are regulated can help develop better drugs for skin diseases.

New targeted therapies for hair loss from alopecia areata show promise, with personalized treatment expected in the future.

PGA-4HGF may help treat hair loss by activating hair growth pathways and extending the hair growth phase.

Cepharanthine, a Japanese hair loss drug, shows promise as a COVID-19 treatment but needs more testing.

Minoxidil dissolves better in propylene glycol + water than in supercritical CO2.

Changing allopregnanolone levels in baby rats affects their adult behavior and alcohol use.

Colchicine can inhibit hair growth by affecting cell activity and protein expression in hair follicles.

A new compound shows promise as a topical treatment for hair loss.

The skin is a complex barrier for drug penetration, but understanding its structure and interactions can improve drug delivery methods.

Nanotechnology in dermatology shows promise for better drug delivery and treatment effectiveness but requires more safety research.

Nanotechnology is improving drug delivery and targeting, with promising applications in cancer treatment, gene therapy, and cosmetics, but challenges remain in ensuring precise delivery and safety.

Ethosomal carriers effectively deliver hair loss drug into skin.

Chitosan-decorated nanoparticles can improve skin delivery and reduce side effects of finasteride.

Most drugs fail to reach the market, but understanding their properties and using strategies like early toxicity tests and drug repurposing can help advance their development.

Polymeric microneedles offer a less invasive, long-lasting drug delivery method that improves patient compliance and reduces side effects.

Hair follicles help absorb and store topical compounds, aiding targeted drug delivery.

Keratin films from human hair can potentially replace human nail plates for drug testing.

Dye enters hair at the edges of cuticle cells and penetrates more from water than alcohol-based solutions.

The new formulation improved the skin absorption of the drug Thiocolchicoside.

GC10/DOX hydrogel shows promise as an effective thyroid cancer treatment.

Improved tablets lead to faster, better drug absorption for hair loss treatment.

Low-frequency electromagnetic fields can boost molecules related to hair growth in human skin cells.

Some skin medications can have harmful interactions with the COVID-19 drug nirmatrelvir-ritonavir, but not with molnupiravir.